OptimizeRx Corporation (OPRX)
Nasdaq · Healthcare · Health Information Services
$8.72+1.75%as of Oct 6, 2026, 7:35 AM ET
- Market cap
- $164M
- P/E (trailing)
- 36.3
- Forward P/E
- 8.3
- 52-week range
- $4.54 – $22.25
- 52-week change
- −52.26%
- EPS (trailing)
- $0.24
- Analyst rating
- 1.2 Strong buy
- Next earnings
- Nov 5, 2026
Fiscal year to Dec 2025
- Revenue
- $109M (+18.78%)
- Net income
- $5.1M
- Operating margin
- 10.7%
- Diluted EPS
- $0.27
- Free cash flow
- $18.7M
From the company’s annual report on SEC EDGAR.
About OptimizeRx Corporation
OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. The company also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms.
Headquarters: Waltham, United States · 132 employees · optimizerx.com